TrialActa dermato-venereologica2025

Safety, Pharmacokinetics, and Efficiency of JS005, a Novel Anti-interleukin-17A Monoclonal Antibody, in Healthy Chinese Adults and Patients with Moderate to Severe Psoriasis.

Lin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.